Objective: Patients with medication-related osteonecrosis of the jaw (MRONJ) often visit their
dentists at advanced stages and subsequently require treatments that greatly affect quality of …

Objective This paper aims to describe the 2023 update position paper on MRONJ
developed by the Italian Societies of Oral Pathology and Medicine (SIPMO) and of …

Objectives: Antiresorptive agent-related osteonecrosis of the jaw (ARONJ)/medication-
related osteonecrosis of the jaw (MRONJ) include both bisphosphonate-related …

Objectives To establish osteonecrosis of the jaws in rats treated with different doses of
zoledronic acid (ZA). Methods Male Wistar rats (n= 6–7) received three consecutive weekly …

Objective To investigate the quantitative SPECT/CT imaging for medication-related
osteonecrosis of the jaw (MRONJ) using volume-based parameters. Methods Thirteen …

Objectives: The purpose of this case-control study was to find a correlation between certain
imaging findings in dental panoramic radiographs and the risk for developing a medication …

Purpose Details regarding risk factors, onset, and outcomes for denosumab-related
osteonecrosis (DRONJ) are sparse. This study examines the clinical characteristics and …

Objective The current staging system of medicine-related osteonecrosis of the jaws
(MRONJ) assigns patients to different stages based on clinical manifestations. The extent of …

AIM To investigate the diagnostic ability of maximum standardised uptake value (SUV max)
at combined single-photon-emission computed tomography/computed tomography …

Purpose To present characteristic findings of Tc-99m hydroxymethylene diphosphonate
(HMDP) scintigraphy, computed tomography (CT), and magnetic resonance (MR) imaging …